Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
NU E Power Corp. Announces Closing of Non-Brokered Private Placement for $1.7 Million. (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Kiromic BioPharma Inc (EM) KRBPQ

Healthcare Biotechnology
Kiromic BioPharma, Inc., a clinical stage biotherapeutics company, engages in the utilization of non-engineered an engineered allogeneic Gamma Delta T (GDT) cell technologies to develop therapies for solid tumors in the United States. The company’s lead product candidate is the Deltacel-01, which is in Phase 1 clinical trial, in combination with low-dose targeted radiation for patients with non... see more

Current News (EXPM:KRBPQ)

Kiromic BioPharma Reports Patient 4 in Deltacel-01 Clinical Trial Reaches 10-Month Progression-Free Survival

Business Wire February 18, 2025

Kiromic BioPharma Reports Tumor Volume Decrease in Two Patients Enrolled in Deltacel-01

Business Wire January 21, 2025

Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01

Business Wire December 12, 2024

Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation

Business Wire December 3, 2024

Kiromic BioPharma Reports Favorable Ongoing Clinical Results From Fourth and Sixth Patients Enrolled in Deltacel-01

Business Wire October 8, 2024

Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical Trial

Business Wire October 1, 2024

Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial

Business Wire September 19, 2024

Kiromic BioPharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation

Business Wire September 19, 2024

Kiromic BioPharma's Deltacel Receives FDA Fast Track Designation

Business Wire August 14, 2024
View More News ››

Opinion & Analysis (EXPM:KRBPQ)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:KRBPQ)

KRBP ..... Halted for the 6th time....vols are increasing

Share price also Watch and wait
Iseneschal - May 3, 2023

KRBP ..... This could gap up today

Expect the unexpected
Iseneschal - May 3, 2023

KRBP ..... Glad I kept some

Ripping to new highs ; )
Iseneschal - May 3, 2023

KRBP..... Sorry about the late post

Sold into the early a.m rip in 1 a/c Still holding a position  Cheers
Iseneschal - May 3, 2023

KRBP...... see my previous posts ; )

Ya just never know..... double digits  Cheers
Iseneschal - May 3, 2023

KRBP.... 3 cents shy of N.H.O.D

Super thin trader  C u at $10
Iseneschal - April 27, 2023
View more Bullboard ››

Lode Gold Resources Inc.

Lode Gold Resources Inc.

Lode Gold Resources Inc., together with its subsidiaries, engages in the acquisition and exploration of mineral resource ...
View More »

Podcasts